Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
about
Neurogenetics and pharmacology of learning, motivation, and cognitionComputational Psychiatry: towards a mathematically informed understanding of mental illnessStimulus discriminability may bias value-based probabilistic learningMultispectral brain morphometry in Tourette syndrome persisting into adulthood.An Integrative Perspective on the Role of Dopamine in SchizophreniaRole of dopamine D2 receptors in human reinforcement learningFrom reinforcement learning models to psychiatric and neurological disorders.Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.Differential modulation of reinforcement learning by D2 dopamine and NMDA glutamate receptor antagonism.Dopaminergic genes predict individual differences in susceptibility to confirmation bias.Neural mechanisms of acquired phasic dopamine responses in learning.The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers.CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning.Mechanisms of hierarchical reinforcement learning in corticostriatal circuits 1: computational analysis.Mind matters: placebo enhances reward learning in Parkinson's disease.Cognition, Emotion and Behavior in Children with Tourette's Syndrome and Children with ADHD-Combined Subtype-A Two-Year Follow-Up Study.Valence-dependent influence of serotonin depletion on model-based choice strategy.Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.The Computational Development of Reinforcement Learning during Adolescence.Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome.Reward and decision processes in the brains of humans and nonhuman primatesMeasuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia.A specific role for serotonin in overcoming effort costNeurophysiology of performance monitoring and adaptive behavior.Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective.Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease.Reward Prediction Errors in Drug Addiction and Parkinson's Disease: from Neurophysiology to Neuroimaging.A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease.Dopamine-dependent reinforcement of motor skill learning: evidence from Gilles de la Tourette syndrome.Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome.Subliminally and Supraliminally Acquired Long-Term Memories Jointly Bias Delayed Decisions.How prediction errors shape perception, attention, and motivation.Levodopa enhances reward learning but impairs reversal learning in Parkinson's disease patients.Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?Separating the effect of reward from corrective feedback during learning in patients with Parkinson's disease.Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.What's in a word? How instructions, suggestions, and social information change pain and emotion.Reward learning deficits in Parkinson's disease depend on depression.Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning.Cerebellar neurophysiology in Gilles de la Tourette syndrome and its role as a target for therapeutic intervention.
P2860
Q24602643-52ED9B87-AB9C-4D5B-899D-3F4A15E2EEFDQ28081014-7C8BCB2F-3B99-43C1-91B6-F199485CBD77Q33648106-8CDFCD2E-A36E-4875-BA01-42C3F4C556B4Q33744798-09D45EF7-08C1-4FF2-A8DB-358D2E75E810Q33839379-A9B57B03-F837-45F4-BF5A-BA6FA93C7FA0Q34068893-9BFAFEA4-6092-4469-A05D-320B6A559D6AQ34161002-F4F8EF79-BA0D-4635-A019-7D82B3C5BE01Q34574292-61A34565-AD52-4373-8D69-E765884B30CFQ34674907-602C7381-DA82-44FA-80C3-8F29BCF3191BQ34994120-44FF9FC4-C981-4B2F-BE6E-623B620E2FEFQ35014907-F10931C9-36F4-4FDB-95F5-A49C09EF2FB3Q35178035-9F5EB483-A7B4-4685-822B-9F8BE9983A37Q35632497-85036EDE-F91D-4D83-97D2-29B7713A77A6Q35753384-D55DCFB9-78C1-4B17-A8FD-EBE3468A0D96Q35854824-043E0C63-0DFD-41EB-B26A-86A5C1755F35Q35870311-AAE4F101-20CF-4653-881A-FA8BE528A725Q35901445-47463B79-05B6-4B72-ADA1-3583FBBB9B37Q35986681-1FAEEC0A-8A08-4004-978B-C249CBCEE75AQ36056805-DB66CFCF-B64D-4041-B9C6-7B714179827AQ36328102-97872E4E-B0CC-405A-AE2F-D8A5FAB7B620Q36784253-1386DBF9-5CDE-4D2C-8B23-A3DAFBCA30B4Q37360680-3D20CDC9-C6BB-4B69-A4BB-E11E37618383Q37401719-E237669F-E7D8-4422-88E9-9E901D794994Q38175133-2C2F409A-CB4E-4C8A-91FB-CCEDD5976F37Q38206496-CBB250EC-6E80-4299-A4BF-21BA56240FFFQ38660355-5CAF4222-600C-4F58-9292-31B177D73C1CQ38729245-0715A9CD-06E2-461D-AF45-E9A5B213DAE4Q39502291-1465047B-A46C-48B4-B3A9-3D91CF3672C4Q39732542-CC15EDEE-0C1C-4135-9F80-53B77AE2E6FDQ41108507-A9F3F74B-F7C1-4660-BC38-A62AFE15C130Q41684819-3FFFD6EF-13D2-42D1-9403-90185CBA363EQ41873192-C0D2643E-4445-46CB-B16D-5255401D8BC7Q42586917-15B14885-0C15-4E52-B9A1-89B4C276C1ABQ45258267-3DB4ED9E-031C-474B-A8DC-E1D25435C4DEQ46395485-6FA66D93-3F85-4B85-AC06-2A65111C2393Q47566821-49079C5B-67F8-43C0-9AF8-A8CC63715356Q47599009-35ADE637-723E-4591-8B5E-20CEB273C714Q47925805-ACE30703-9855-48E5-8398-54D08A36B9C3Q48278827-D7C4C671-86F5-4027-A7DA-3A1198681559Q50545788-198C2F8D-403C-4970-AFA7-D8A06403E14F
P2860
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological modulation of ...... on's and Tourette's syndromes.
@en
Pharmacological modulation of ...... on's and Tourette's syndromes.
@nl
type
label
Pharmacological modulation of ...... on's and Tourette's syndromes.
@en
Pharmacological modulation of ...... on's and Tourette's syndromes.
@nl
prefLabel
Pharmacological modulation of ...... on's and Tourette's syndromes.
@en
Pharmacological modulation of ...... on's and Tourette's syndromes.
@nl
P2093
P2860
P50
P356
P1476
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes
@en
P2093
Andreas Hartmann
David Grabli
Mathias Pessiglione
P2860
P304
19179-19184
P356
10.1073/PNAS.0904035106
P407
P577
2009-10-22T00:00:00Z